Company Monitoring Page for Amgen

job ratings (see below graph) for Amgen

latest headlines for company on cafepharma

How Good Is AbbVie's Humira Deal With Amgen?
Motley Fool
Fri, 09/29/17 - 10:06 am
Tags:
AbbVie, Amgen, Humira, biosimilars, Amjevita
Under Amgen and AbbVie agreement, rival drug to AbbVie's Humira expected to launch in 2023
Marketwatch
Thu, 09/28/17 - 09:50 am
Tags:
Amgen, AbbVie, Humira, Amgevita, biosimilars, drug launches
Amgen targets China in cancer biosimilar development deal with Simcere
Fierce Pharma
Thu, 09/28/17 - 09:43 am
Tags:
Amgen, China, biosimilars, drug development, Simcere
Amgen reaffirms 2017 guidance in wake of Hurricane Maria
Marketwatch
Mon, 09/25/17 - 09:56 am
Tags:
Amgen, Puerto Rico, drug manufacturing
Pharma executives wary of value-based deals, but see the potential benefits: PwC
Fierce Pharma
Fri, 09/22/17 - 11:13 am
Tags:
value-based contracts, Amgen, Novartis, Sanofi, Merck
Sanofi and Amgen, eyeing boost for PCSK9 use, tout benefits for diabetes patients
Fierce Pharma
Mon, 09/18/17 - 11:08 am
Tags:
Sanofi, Amgen, PCSK9 inhibitors, diabetes, Regeneron, Praluent, Repatha
Why Amgen, Lilly, J&J Are Interested In These Small Biotechs
Investors Business Daily
Sat, 09/16/17 - 12:11 pm
Tags:
Amgen, Eli Lilly, JNJ, Exelixis, biotech, Theravance, Bavarian Nordic, Agios, Biohaven Pharmaceuticals, Progenics
FDA commish cheers on biosimilars as Amgen, Allergan score OK for knockoff of Roche’s Avastin
Endpoints
Fri, 09/15/17 - 09:14 am
Tags:
FDA, Scott Gottlieb, Amgen, Allergan, biosimilars, Mvasi, Roche, Avastin
Insurers, doctors battle over new heart disease drugs
CNBC
Fri, 09/8/17 - 09:30 am
Tags:
insurers, cardiovascular disease, statins, PCSK9 inhibitors, Amgen, Regeneron, Sanofi, Repatha, Praluent
AstraZeneca, Amgen whip up some blockbuster excitement with a possible game-changing asthma drug
Endpoints
Thu, 09/7/17 - 09:33 am
Tags:
AstraZeneca, Amgen, tezepelumab, asthma
The Only 2 Biotech Stocks With a Higher Dividend Yield Than the S&P 500
Motley Fool
Mon, 09/4/17 - 10:33 pm
Tags:
biotech stocks, Amgen, Gilead Sciences
Key FDA Regulatory Events to Watch Out for in Sep 2017
Yahoo/Zacks.com
Mon, 09/4/17 - 10:31 pm
Tags:
FDA, Mylan Labs, Herceptin, biosimilars, trastuzumab, Shingrix, GSK, Pfizer, Sutent, PTC Therapeutics, Translarna, Amgen, Allergan, Avastin
Is the System Rigged Against Biosimilars?
Motley Fool
Sat, 08/26/17 - 12:39 pm
Tags:
biosimilars, Amgen, Amjevita
In cost debate, Amgen stands by Repatha's value
BioPharma Dive
Wed, 08/23/17 - 11:36 am
Tags:
Amgen, Repatha, drug pricing, PCSK9 inhibitors, Praluent, Sanofi, Regeneron
The decade's top 10 patent losses, worth a whopping $915B in lifetime sales
Fierce Pharma
Thu, 08/17/17 - 10:36 am
Tags:
patents, AbbVie, Humira, Pfizer, Lipitor, Norvasc, GSK, Advair, Sanofi, Lantus, JNJ, Remicade, AstraZeneca, Crestor, Nexium, Amgen, Neulasta, Novartis, Diovan
Amgen rolls new Prolia osteoporosis ads, just weeks after next-gen Evenity hits a snag
Fierce Pharma
Wed, 08/16/17 - 09:39 pm
Tags:
Amgen, Prolia, osteoporosis, drug ads
What Kyprolis Could Do for Amgen’s Revenue Growth
Market Realist
Tue, 08/15/17 - 09:38 am
Tags:
Kyprolis, Amgen, Multiple Myeloma
Why Has 2017 Been a Horrible Year So Far for Biotech Acquisitions?
Motley Fool
Mon, 08/14/17 - 10:03 am
Tags:
biotech, M&A, JNJ, Actelion, Takeda, Ariad Pharmaceuticals, Gilead Sciences, Pfizer, Amgen
Amgen falls short in Epogen patent appeal but Pfizer stumble delays competition
Fierce Pharma
Fri, 08/11/17 - 11:22 am
Tags:
Amgen, Epogen, patents, Pfizer, anemia, biosimilars
Amgen Remains A Standout Among Biotechs
Forbes
Tue, 08/8/17 - 11:55 am
Tags:
Amgen, Repatha, biotech

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.